You are here: Home / News / TRADE / Biocredit swab antigen: we should recognize these four points in future epidemic prevention and control

Biocredit swab antigen: we should recognize these four points in future epidemic prevention and control

Publish Time: 2022-04-23     Origin: Site

Recently, the World Health Organization introduced two new autovariants of Omicron ba 4、BA. 5 has been included in the detection list, Xe recombinant virus has also accelerated the spread all over the world, and XD, XL and other strains have also appeared one after another. As COVID-19 continues to mutate, will its speed of transmission be further accelerated? According to the situation and characteristics of this round of national epidemic, what are the tips for the next epidemic prevention and control?

On April 18, medical staff vaccinated the elderly with the new coronavirus vaccine in Dongcheng District, Beijing. Photographed by Ju huanzong of Xinhua News Agency.

At the press conference of the joint defense and joint control mechanism of the State Council held in April 19th, Wu Zunyou, chief expert of China's CDC epidemiology, said that COVID-19 mutation has been continuously occurring. Some of the mutations have changed their biological characteristics, affecting their infectious, pathogenic and immune escape abilities.

Biocredit swab antigen: some people believe that COVID-19 is mutated toward infectious enhancement and diminished pathogenicity

Wu Zunyou said that in fact, from a biological point of view, there is no essential connection between infectivity and pathogenicity. The reverse relationship between these two aspects is more determined by people's sociological attributes. "When the pathogenicity is weakened, the infected people have mild symptoms, have more time for social activities, contact more people, and cause more people to be infected."

Wu Zunyou said that at present, there is no obvious rule of COVID-19 mutation in infectious, pathogenicity and so on. It is possible to develop in the direction of infectious enhancement and pathogenicity weakening, and it may also enhance the direction of infectious enhancement and pathogenicity.

In April 17th, Guangfu neighborhood committee staff in Shanghai Guangfu neighborhood of Yu Garden, Huangpu District, were responsible for disinfection of materials loaded separately. Photo by Xinhua News Agency reporter Jin liwang.

So what should we do with COVID-19, which is constantly changing?

Wu Zunyou suggested: on the one hand, it is necessary to closely track the changes and progress of new variant strains in terms of transmission range, infectivity and pathogenicity all over the world, including whether diagnostic reagents can sensitively detect new variant strains, and the effect of existing vaccines on the prevention of infection, severe illness and death of new variant strains.

On the other hand, adhere to normal prevention and control measures, including the "four early" measures of early detection, early report, early isolation and early treatment. For ordinary people, it is to do a good job in vaccination and adhere to the implementation of personal protective measures, such as wearing masks, paying attention to hand hygiene and maintaining social distance.

According to the situation and characteristics of this round of national epidemic, in the next epidemic prevention and control, Wu Zunyou also reminded all localities to recognize the following four aspects:

1. Prepare ideologically for a long-term struggle;

2. Improve the ability of epidemic prevention and control;

3. Further strengthen the vaccination of Xinguan vaccine;

4. Prepare for the possible large-scale new epidemic.

COOPERATION INTENTION PLEASE LEAVE YOUR EMAIL

Leave your email address, we will send professional service personnel to establish communication with you.  

During the period, we will strictly comply with the terms of stealth service to ensure your information security.  

COOPERATION INTENTION PLEASE LEAVE YOUR EMAIL
  Henan UDX Biotechnology Co.,Ltd
   Building 2,No.206, Xisihuan Road,High-tech Industrial Development Zone, Zhengzhou, Henan China
   marina@udxbio.com
  +86-371-88915816
  +86-371-88915816
    +86-153-33817530
© Copyright  2021 Henan UDX Biotechnology Co.,Ltd. All rights reserved. | Sitemap